NetWorth
LeaderPortfolio
Bawri
Girdhari Lal Bawri
Rank #2246
INDIA•Healthcare•Pharmaceuticals

Girdhari Lal Bawri

Net Worth
$1.825B
0% (24h)
Girdhari Lal Bawri is the Chairman of Macleods Pharmaceuticals, a prominent Indian pharmaceutical company. With a net worth of $1.9 billion, Bawri's wealth stems from his entrepreneurial success in the healthcare sector, specifically from Macleods Pharmaceuticals, which he co-founded in 1986. His career began with his family's pharmacy in Jaipur, providing him with early exposure to the industry. Macleods produces generics for various diseases, including asthma, diabetes, and osteoporosis. Bawri's leadership has been instrumental in positioning Macleods among India's top pharmaceutical firms, contributing significantly to his wealth and the company's global presence.

How to read Girdhari Lal Bawri's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Girdhari Lal Bawri, we anchor the narrative to Pharmaceuticals and Pharmaceuticals, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $1.825B alongside global rank #2246, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (INDIA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Girdhari Lal Bawri's journey began in Jaipur, where his family owned a pharmacy. This early exposure to the pharmaceutical world instilled in him a deep understanding of the industry and patient needs. Bawri's family background in healthcare laid the foundation for his future endeavors.

Rise to Success

In 1986, Bawri, along with his two siblings, co-founded Macleods Pharmaceuticals. Initially, the company focused on producing anti-TB medicines, addressing a critical need in India. This strategic move, driven by both market demand and personal experience, proved successful. Macleods expanded its portfolio to include generics for chronic conditions, contributing to its growth and establishing Bawri as a key figure in the Indian pharmaceutical sector.

Key Business Strategies

Macleods Pharmaceuticals adopted key business strategies. These strategies included export-led growth, therapeutic diversification into generics for chronic conditions, and a focus on family governance. The company's global footprint, particularly in emerging markets, has been a major driver of revenue and profit. Bawri's leadership has ensured regulatory compliance and cost efficiency, contributing to the company's success.

Philanthropy

While specific details on his philanthropic activities are not readily available, Bawri is known to support education and healthcare initiatives, as part of his commitment to giving back to society and uplifting communities. His family's involvement in the same Mumbai building also reflects a close-knit approach to business and personal life.

Career Timeline

1986

Co-founded Macleods Pharmaceuticals

Established Macleods Pharmaceuticals with his siblings to produce anti-TB medicines.

Key Business Ventures & Holdings

CompanyStakeValue
Macleods Pharmaceuticals——

Net Worth History

In-Depth Analysis

Early Life

Girdhari Lal Bawri's journey began in Jaipur, where his family owned a pharmacy. This early exposure to the pharmaceutical world instilled in him a deep understanding of the industry and patient needs. Bawri's family background in healthcare laid the foundation for his future endeavors.

Rise to Success

In 1986, Bawri, along with his two siblings, co-founded Macleods Pharmaceuticals. Initially, the company focused on producing anti-TB medicines, addressing a critical need in India. This strategic move, driven by both market demand and personal experience, proved successful. Macleods expanded its portfolio to include generics for chronic conditions, contributing to its growth and establishing Bawri as a key figure in the Indian pharmaceutical sector.

Key Business Strategies

Macleods Pharmaceuticals adopted key business strategies. These strategies included export-led growth, therapeutic diversification into generics for chronic conditions, and a focus on family governance. The company's global footprint, particularly in emerging markets, has been a major driver of revenue and profit. Bawri's leadership has ensured regulatory compliance and cost efficiency, contributing to the company's success.

Philanthropy

While specific details on his philanthropic activities are not readily available, Bawri is known to support education and healthcare initiatives, as part of his commitment to giving back to society and uplifting communities. His family's involvement in the same Mumbai building also reflects a close-knit approach to business and personal life.

Data Sources & Methodology

Figures for Girdhari Lal Bawri are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.

You may also like

HubAll BillionairesHubGlobal RankingsHubNewsroom